RE: If it is 1.5% , makes no sense to me at all19 Dec 2024 18:26
TT has been getting equity stakes and revenue confused for months now. And if Bio brought in $1billion of revenue, it'd be worth many multiples of billions in market cap, of which ciz would have 1.5% AND 10% of revenues of the lung test.
I don't think he's stupid, so I have to assume its a deliberate misread, talking down the sp to a price that he does "like what he sees" to buy in again.
Personally, I think its currently hard to tell what the ciz value is, hence the poor sp action. They are vauge or omit things in RNS's like this key information around the equity stake, which is frustrating. My own view is the test will succ